Swirsky Douglas J 4
4 · Cellectar Biosciences, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Swirsky Douglas J
Director
Transactions
- Award
Stock option (right to buy)
2022-06-24+11,700→ 11,700 totalExercise: $4.10Exp: 2032-06-24→ Common Stock (11,700 underlying)
Footnotes (2)
- [F1]Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022.
- [F2]This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date.